South-East Asian Region
The total estimated cost of the Global Plan in the South-East Asia Region is about US$6.2 billion.
The funding gap is estimated at US$3.4 billion.
During the period of the Plan (2006-2015), it is estimated that at least 16 million people will be treated in DOTS programmes and more than 145 000 in DOTS-Plus. In addition, 306 000 TB patients will be enrolled on antiretroviral therapy.
The combined effect of all interventions will be to prevent about 5.1 million deaths, in comparison with a situation in which no DOTS programmes are implemented.
The South-East Asian Region is the Region second-hardest hit by the HIV-epidemic, after sub-Saharan Africa. More than 6 million people were estimated to be living with HIV in December 2004. The extent of TB/HIV coinfection in the Region will depend on the future course of the HIV epidemic, as well as on efforts to control TB.
The Global Plan in the South-East Asian Region
Total cost: US $6.2 billion
Country activities:
- DOTS Expansion
- DOTS-Plus
- TB/HIV
- ACSM
Patients treated: 16 million
Lives saved: 5.1 million
Available funding: US$2.8 billion
Total funding gap: US$3.4 billion
Charts
Estimated costs and impacts of planned intensified activities 2006-2015 [.pdf]
